Phase
Condition
Joint Injuries
Treatment
Questionnaire
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
The patient must have given their free and informed consent and signed the consentform
The patient must be a member or beneficiary of a health insurance plan
The patient is at least 18 years old
The patient has rheumatoid polyarthritis as defined by the ACR-EULAR 2010 criteria,treated orally or subcutaneously with MTX for at least 3 months with a stable (unchanged) dosage for at least 1 month, and a stable (unchanged) route ofadministration for at least 1 month. And no planned change in Methotrexate intake atleast until the second study visit. Other treatments at the same time are authorized
Exclusion
Exclusion Criteria:
The subject is participating in an interventional study, or is in a period ofexclusion determined by a previous study
The subject refuses to sign the consent
It is impossible to give the subject informed information
The patient is under safeguard of justice or state guardianship
The subject has a contraindication to taking methotrexate (including a patient witha desire to become pregnant).
Study Design
Connect with a study center
CHU Bordeaux
Bordeaux, 33000
FranceSite Not Available
CHRU Montpellier
Montpellier, 34295
FranceSite Not Available
CHU Nimes
Nîmes, 30029
FranceActive - Recruiting
CHU Toulouse
Toulouse, 31300
FranceSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.